LSD-assisted therapy for alcohol use disorder
Treatments studied
Part of Mental health clinical trials.
This Phase 2 trial studies whether an LSD treatment approach, combined with study procedures, can help people with moderate-to-severe alcohol use disorder cut down or stop drinking. It may help reset patterns around cravings and drinking, but it also requires careful safety screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 25 or older
- Have moderate-to-severe alcohol use disorder based on DSM-5 criteria
- Plan to stop or significantly decrease alcohol use for the whole study
- Have had alcohol detox within the last 60 days, or (if detox wasn’t needed) been alcohol-free for at least 14 days
- Had heavy drinking recently (at least 4 “heavy drinking days” in the last 30 days)
- Not start formal alcohol-use treatments during the double-blind study period
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether psilocybin (a psychedelic compound) combined with talk therapy can help people who have both major depression and alcohol use disorder. The goal is to see if it can improve mood and reduce drinking.
This trial tests whether N-acetylcysteine (a supplement-like medicine) can help people with alcohol use disorder reduce or stop drinking. You may be randomly assigned to receive N-acetylcysteine or a comparison treatment, and you’ll complete interviews during the study.
This Phase 2 study tests a program designed to help people cut down or stop heavy alcohol use and daily smoking at the same time. It will check your alcohol level at the start and uses urine tests during a short induction phase to confirm recent alcohol and ongoing smoking.
This Phase 2 study tests how LSD may affect comfort and quality of life for people with advanced or end-stage life-limiting illness. It also checks whether the medicine is safe and can be given in a controlled way in palliative care settings.
This trial tests whether a non-invasive brain stimulation technique, called transcranial direct current stimulation (tDCS), can help people with alcohol use disorder reduce their drinking. It is for people who want to cut down but are not necessarily ready to stop completely.
This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.
Hear when a new Alcohol Use Disorder (AUD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.